EC Number   |
IC50 Value |
IC50 Value Maximum |
Inhibitor |
Reference |
|---|
   7.2.2.3 | 0.000001 |
- |
(3beta,22alpha,25R)-spirostan-3-yl O-D-apio-beta-D-furanosyl-(1-2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1-4)]-beta-D-glucopyranoside |
obtained by extrapolation of half maximal inhibition |
701427 |
| 7.2.2.3 | 0.00001 |
- |
(3beta,22alpha,25R)-26-(beta-D-glucopyranosyloxy)-2-methoxyfurost-5-en-3-yl O-D-apio-beta-D-furanosyl-(1-2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1-4)]-beta-D-glucopyranoside |
obtained by extrapolation of half maximal inhibition |
701427 |
| 7.2.2.3 | 0.0001 |
- |
ceramide |
pH 7.4, 37°C |
711013 |
| 7.2.2.3 | 0.0001 |
- |
sodium orthovanadate |
- |
686609 |
| 7.2.2.3 | 0.0091 |
- |
vanadate |
pH and temperature not specified in the publication |
718973 |
| 7.2.2.3 | 0.044 |
- |
miltefosine |
- |
695869 |
| 7.2.2.3 | 0.053 |
- |
[(dihydroindenyl)oxy]acetic acid |
- |
686551 |
| 7.2.2.3 | 0.095 |
- |
[(dihydroindenyl)oxy]acetic acid |
endogenous Na+,K+-ATPase |
686551 |
| 7.2.2.3 | 0.22 |
- |
Furosemide |
in homogenate of clone CL14 |
695869 |
| 7.2.2.3 | 0.27 |
- |
Furosemide |
- |
686609 |
